PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15354385-0	2004	MTHFR C677T polymorphism, folic acid and hyperhomocysteinemia in levodopa treated patients with Parkinson"s disease.	Levodopa	65-73	methylenetetrahydrofolate reductase	Homo sapiens	0-5	
22354693-0	2012	Coenzyme Q10, hyperhomocysteinemia and MTHFR C677T polymorphism in levodopa-treated Parkinson"s disease patients.	Levodopa	67-75	methylenetetrahydrofolate reductase	Homo sapiens	39-44	
19786283-0	2009	Methylenetetrahydrofolate reductase polymorphisms and plasma homocysteine in levodopa-treated and non-treated Parkinson"s disease patients.	Levodopa	77-85	methylenetetrahydrofolate reductase	Homo sapiens	0-35	
17914182-0	2007	Effect of MTHFR polymorphisms on hyperhomocysteinemia in levodopa-treated Parkinsonian patients.	Levodopa	57-65	methylenetetrahydrofolate reductase	Homo sapiens	10-15	
17914182-2	2007	In this study, we investigated the effects of C677T and A1298C MTHFR polymorphisms, in association with L-DOPA daily dose and vitamin status, on hyperhomocysteinemia development in PD patients.	Levodopa	104-110	methylenetetrahydrofolate reductase	Homo sapiens	63-68	
16774768-9	2006	In conclusion, MTHFR C677T genotype is a significant factor for hyperhomocysteinemia in patients with PD, levodopa-untreated and probably even more in levodopa-treated PD patients.	Levodopa	106-114	methylenetetrahydrofolate reductase	Homo sapiens	15-20	
16774768-9	2006	In conclusion, MTHFR C677T genotype is a significant factor for hyperhomocysteinemia in patients with PD, levodopa-untreated and probably even more in levodopa-treated PD patients.	Levodopa	151-159	methylenetetrahydrofolate reductase	Homo sapiens	15-20	
11160979-0	2001	Plasma homocysteine and MTHFR C677T genotype in levodopa-treated patients with PD.	Levodopa	48-56	methylenetetrahydrofolate reductase	Homo sapiens	24-29	
12614926-8	2003	Moreover, a prolonged duration of treatment with L-DOPA in patients with MTHFR T/T genotype enhanced the hypertrophy of IMC, compared with patients with the C/C or C/T genotype.	Levodopa	49-55	methylenetetrahydrofolate reductase	Homo sapiens	73-78	
11271164-0	2001	Plasma homocysteine and MTHFR C677T genotype in levodopa-treated patients with PD.	Levodopa	48-56	methylenetetrahydrofolate reductase	Homo sapiens	24-29	
10932284-0	2000	Plasma homocysteine and MTHFR C677T genotype in levodopa-treated patients with PD.	Levodopa	48-56	methylenetetrahydrofolate reductase	Homo sapiens	24-29